Neuronal pentraxin Nptx2 regulates complement activity in the brain

Complement overactivation mediates microglial synapse elimination in neurological diseases like Alzheimer’s disease and frontotemporal dementia (FTD), but how complement activity is regulated in the brain remains largely unknown. We identified that the secreted neuronal pentraxin Nptx2 binds complement C1q and thereby regulates its activity in the brain. Nptx2-deficient mice show increased complement activity and C1q-dependent microglial synapse engulfment and loss of excitatory synapses. In a neuroinflammation culture model and in aged TauP301S mice, AAV-mediated neuronal overexpression of Nptx2 was sufficient to restrain complement activity and ameliorate microglia-mediated synapse loss. Analysis of human CSF samples from a genetic FTD cohort revealed significantly reduced levels of Nptx2 and Nptx2-C1q protein complexes in symptomatic patients, which correlated with elevated C1q and activated C3. Together, these results show that Nptx2 regulates complement activity and microglial synapse elimination in the healthy and diseased brain and that diminished Nptx2 levels might exacerbate complement-mediated neurodegeneration in FTD patients.

[1]  Nick C Fox,et al.  Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study , 2022, Journal of Neuroinflammation.

[2]  K. Kekesi,et al.  Competitive inhibition of the classical complement pathway using exogenous single-chain C1q recognition proteins , 2022, The Journal of biological chemistry.

[3]  Velina Kozareva,et al.  A High-Efficiency AAV for Endothelial Cell Transduction Throughout the Central Nervous System , 2022, Nature Cardiovascular Research.

[4]  R. Faull,et al.  Microglia Mediate Early Corticostriatal Synapse Loss and Cognitive Dysfunction in Huntington’s Disease Through Complement-Dependent Mechanisms , 2021, bioRxiv.

[5]  Jennifer M. Coughlin,et al.  A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function , 2021, Science advances.

[6]  Nick C Fox,et al.  A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia , 2021, Brain : a journal of neurology.

[7]  Su Z. Hong,et al.  All-or-none disconnection of pyramidal inputs onto parvalbumin-positive interneurons gates ocular dominance plasticity , 2021, Proceedings of the National Academy of Sciences.

[8]  Christopher W. Whelan,et al.  Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice , 2020, Nature Neuroscience.

[9]  S. R. Datta,et al.  GABA-receptive microglia selectively sculpt developing inhibitory circuits , 2020, Cell.

[10]  S. Mccarroll,et al.  CUB and Sushi Multiple Domains 1 (CSMD1) opposes the complement cascade in neural tissues , 2020, bioRxiv.

[11]  P. Worley,et al.  Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome , 2020, Molecular Neurodegeneration.

[12]  Rohit Reja,et al.  Ubiquitin Ligase COP1 Suppresses Neuroinflammation by Degrading c/EBPβ in Microglia , 2020, Cell.

[13]  G. Sia,et al.  The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development , 2020, Nature Neuroscience.

[14]  Christopher W. Whelan,et al.  Complement genes contribute sex-biased vulnerability in diverse disorders , 2020, Nature.

[15]  P. Worley,et al.  Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[16]  P. Worley,et al.  Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease , 2019, Alzheimer's & dementia.

[17]  Christopher J. Bohlen,et al.  Microglia in Brain Development, Homeostasis, and Neurodegeneration. , 2019, Annual review of genetics.

[18]  G. Mentis,et al.  The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA , 2019, Cell reports.

[19]  Melanie A. Huntley,et al.  Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. , 2019, Cell reports.

[20]  D. Wilton,et al.  Neuron-Glia Signaling in Synapse Elimination. , 2019, Annual review of neuroscience.

[21]  M. Albert,et al.  Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults , 2019, Front. Aging Neurosci..

[22]  A. Cruz-Martín,et al.  Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction , 2019, bioRxiv.

[23]  C. Weber,et al.  ApoE attenuates unresolvable inflammation by complex formation with activated C1q , 2019, Nature Medicine.

[24]  Melanie A. Huntley,et al.  Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies , 2018, Neuron.

[25]  J. Saura,et al.  RNA-Seq transcriptomic profiling of primary murine microglia treated with LPS or LPS + IFNγ , 2018, Scientific Reports.

[26]  W. M. van der Flier,et al.  Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach , 2018, Alzheimer's & Dementia.

[27]  Boaz Styr,et al.  Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease , 2018, Nature Neuroscience.

[28]  T. Yednock,et al.  Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases , 2017, International journal of toxicology.

[29]  C. Gross,et al.  Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders , 2017, Nature Reviews Neuroscience.

[30]  Douglas Galasko,et al.  NPTX2 and cognitive dysfunction in Alzheimer’s Disease , 2017, eLife.

[31]  T. Südhof,et al.  Presynaptic Neuronal Pentraxin Receptor Organizes Excitatory and Inhibitory Synapses , 2017, The Journal of Neuroscience.

[32]  Robert E. Schmidt,et al.  A complement–microglial axis drives synapse loss during virus-induced memory impairment , 2016, Nature.

[33]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[34]  Michelle K. Cahill,et al.  Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation , 2016, Cell.

[35]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[36]  R. Huganir,et al.  Glutamate synapses in human cognitive disorders. , 2015, Annual review of neuroscience.

[37]  P. Worley,et al.  Pentraxins Coordinate Excitatory Synapse Maturation and Circuit Integration of Parvalbumin Interneurons , 2015, Neuron.

[38]  J. Ploski,et al.  The production of viral vectors designed to express large and difficult to express transgenes within neurons , 2015, Molecular Brain.

[39]  E. Huang,et al.  A Dramatic Increase of C1q Protein in the CNS during Normal Aging , 2013, The Journal of Neuroscience.

[40]  A. Kirkwood,et al.  Obligatory Role for the Immediate Early Gene NARP in Critical Period Plasticity , 2013, Neuron.

[41]  S. Pradervand,et al.  Comprehensive Expression Analyses of Neural Cell-Type-Specific miRNAs Identify New Determinants of the Specification and Maintenance of Neuronal Phenotypes , 2013, The Journal of Neuroscience.

[42]  Ben A. Barres,et al.  Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.

[43]  Ulf Landegren,et al.  Sensitive Plasma Protein Analysis by Microparticle-based Proximity Ligation Assays* , 2009, Molecular & Cellular Proteomics.

[44]  Steffen B. E. Wolff,et al.  mGluR1/5-Dependent Long-Term Depression Requires the Regulated Ectodomain Cleavage of Neuronal Pentraxin NPR by TACE , 2008, Neuron.

[45]  John D. Lambris,et al.  The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.

[46]  R. Huganir,et al.  Interaction of the N-Terminal Domain of the AMPA Receptor GluR4 Subunit with the Neuronal Pentraxin NP1 Mediates GluR4 Synaptic Recruitment , 2007, Neuron.

[47]  R. O’Brien,et al.  Narp and NP1 Form Heterocomplexes that Function in Developmental and Activity-Dependent Synaptic Plasticity , 2003, Neuron.

[48]  A. Mantovani,et al.  Biochemical and functional characterization of the interaction between pentraxin 3 and C1q , 2003, European journal of immunology.

[49]  O. Steward,et al.  Synaptic Clustering of AMPA Receptors by the Extracellular Immediate-Early Gene Product Narp , 1999, Neuron.

[50]  G. Ren,et al.  Optimized negative-staining electron microscopy for lipoprotein studies. , 2013, Biochimica et biophysica acta.